The global HPV Testing and Pap Test Market was valued at around USD 2.2 Billion in 2021. With a projected CAGR of 19.3% for the next ten years, the market is likely to reach a valuation of approximately USD 15 Billion by the end of 2032.
| Attributes | Details |
|---|---|
| HPV Testing and Pap Test Market Size (2021A) | USD 2.2 Billion |
| Estimated Market Value (2022E) | USD 2.6 Billion |
| Forecasted Market Value (2032) | USD 15 Billion |
| Global Market Growth Rate (2022 to 2032) | 19.3% CAGR |
| United States Forecasted Market Value (2032) | USD 5.9 Billion |
| USA Growth Rate(2022 to 2032) | 20.4% CAGR |
| Key Companies Covered | Abbott Laboratories Qiagen N.V.; Becton Dickinson and Company; Quest Diagnostics Inc.; Hologic Inc.; F. Hoffmann-La Roche; Femasys Inc.; Arbor Vita Corporation; NURX Inc.; Seegene Inc.; Thermo Fisher Scientific. Inc.; bioMérieux SA |
Future Market Insights’ analysis reveals that most of the HPV Testing and Pap Test market revenue are grossed from Pap Tests, which have a predicted CAGR of 16.8% by 2032. Cervical Cancer Screening is the top application of these tests, with a CAGR of 18.4% in the forecast period. HVC and Pap tests are used extensively in Cervical Cancer Screening and awareness drives, government policies, and programs provide a significant demand boost.
The global HPV Testing and Pap Test market expanded at a CAGR of 17.2% from 2015 to 2021. The global market is predicted to surge ahead at a CAGR of 19.3% and record sales worth USD 15 Billion by the end of 2032, registering an absolute dollar opportunity of USD 12 Billion from 2022 to 2032.
Cervical cancer is the 4th most common form of cancer amongst women worldwide. In 2020, there were an estimated 604,000 new cases and 342,000 related deaths. Cervical cancer is most treatable and curable if vaccinations are effective and the cancer is detected at an early stage and proper treatment is given promptly.
If detected at an early stage, the 5-year survival rate is very high at around 92%. Even cancers at later stages can be managed with proper treatment and care. The global strategy for cervical cancer elimination, endorsed by the WHO in 2020, aims for 70% of women globally to have undergone testing at regular intervals by 2030.
The policy is based on the idea that implementing this, along with other policies regarding treatment and vaccination could eliminate cervical cancer deaths in a century. According to the WHO, this could prevent around 62 million deaths.
Pap testing, which tests for cell changes that could potentially be or become cervical cancer, and HPV testing, which looks for high-risk HPV are globally recommended. In recent years, demand is increasing due to increased awareness, developments in reducing costs, and government policies and programs.
There have been a number of government programs and policies that are boosting the global demand for testing. In the USA, the CDC recommends a Pap test or cytology test once every 3 years for 21-29-year-olds and a pap test every 3 years or an HPV test every 5 years, or a cotest of both Pap and HPV tests every 5 years for those over 30 years.
In China, the All-China Women's Federation and the Ministry of Health launched a dual program for screening cervical and breast cancer in rural women, at 3-year intervals. In Japan, the National Cancer Center recommends screening every 2 years.
Most cities offer free or subsidized options for women of eligible age groups. In South Korea, which has a single-payer public health insurance system, eligible women over 20 years of age are provided a free screening once every 2 years.
Nearly 90% of HPV deaths occurring in 2020, occurred in low and middle-income countries; largely owing to the fact that low-resource areas often do not have the ability to provide regular screening. A commonly used method is Visual Inspection with Acetic Acid or VIA testing which involves a health worker applying dilute acetic acid to the cervix and inspecting it for visual signs of whitening with the naked eye.
This method is used despite lower accuracy in low-resource areas since it has lower cost-per-test and is convenient. Another developing technology that has the potential to raise demand in low-resource areas is the use of AI in diagnosis. A team of researchers from the National Cancer Institute (NCI) and Global Good trained an ML algorithm to use Automated Visual Evaluation (AVE) to analyze images of a cervix and identify changes that could lead to cancer. The images can be taken with even a simple camera. New developments such as training the algorithm with a more global set of images to account for geographic variations are expected to eventually raise demand.
Cervical Cancer Screening is the top application for HPV testing and Pap Testing, with a CAGR of 16.7% from 2015 to 2021. The forecasted CAGR for this category is 18.4% for the period 2022 to 2032.
Neither HPV testing nor the Pap test can detect vaginal cancer on its own, but they do detect cervical cancer and pre-cancerous conditions- which are often precursors to vaginal cancer, and HPV, which increases the risk of developing vaginal cancer.
Europe is an emerging HPV Testing and Pap Test market for HPV and Pap tests. According to the European Centre for Disease Prevention and Control or the ECDC, 2.5% of all cancers in Europe are caused by HPV, and Cervical cancer is the second most common type of cancer in women of the 15 to 55 age group, after only breast cancer.
Awareness drives and official programs are driving demand. For example, in the United Kingdom, the NHS provides free tests to women every 3 years if in the 25 to 29 age category and every 5 years to women over 50 years of age. The program uses an initial HPV test and an additional Pap Test for cells that test positive.
The USA contributes significantly to the HPV and Pap Tests market, with a forecasted market size of USD 5.9 Billion by 2032. The American cancer society recommends screening with an HPV test or HPV/Pap cotest every 5 years from 25 years of age to 65 years, or a Pap Test every 3 years.
The Centers for Disease Control provides free or low-cost screenings to women who qualify based on factors like income levels and insurance coverage under their National Breast and Cervical Cancer Early Detection Program (NBCCEDP). The HPV Testing and Pap Test market in the country is expected to garner an absolute dollar opportunity of USD 5 Billion. The HPV Testing and Pap Test market in the USA witnessed a CAGR of 18.2% from 2015 to 2021 and is expected to continue growing, with a forecasted CAGR growing at 20.4%.
The HPV Testing and Pap Test market in the United Kingdom is expected to reach a valuation of USD 672.7 Million by 2032. With a projected CAGR of 20.2% from 2022 to 2032, the market is expected to garner an absolute dollar opportunity of USD 567 Million.
The HPV Testing and Pap Test market in Japan is expected to account for USD 795 Million by 2032. Growing at a CAGR of 22.4% from 2022 to 2032, the market is likely to gross an absolute dollar opportunity of USD 689 Million.
The HPV Testing and Pap Test market in South Korea is expected to reach a valuation of USD 241 Million by 2032. The market from 2022 to 2032 is expected to grow at a CAGR to garner an absolute dollar opportunity of USD 194 Million.
PAP tests are the largest contributor to HPV Testing and Pap Test market revenue, having witnessed a CAGR of 16.8% with a forecasted CAGR of 17.5% for the next decade. Their use has led to a significant decrease in Cervical Cancer deaths. However, new WHO guidelines shift to the HPV DNA-based test as preferred over the currently prevalent VIA or Pap Tests.
Despite this, Pap tests, which are the historical method in use, are still useful and common. There are concerns that additional HPV testing would mean an increase in invasive procedures. A combination of both tests is now recommended, with healthcare providers and global programs choosing whether to administer one of the two or both depending on patient age, history, and availability of resources.
HPV Testing and Pap Test providers are focused on increasing the efficiency, accuracy, and affordability of their tests and harnessing new technology. The key companies operating include Abbott Laboratories, Qiagen N.V., Becton, Dickinson and Company, Quest Diagnostics, Inc., Hologic, Inc., F. Hoffmann-La Roche, Femasys, Inc., Arbor Vita Corporation, NURX, Inc., Seegene, Inc., Thermo Fisher Scientific. Inc., and bioMérieux SA
Some of the recent developments in HPV Testing and Pap Tests are as follows:
Similarly, recent developments related to companies manufacturing HPV Testing and Pap Tests have been tracked by the team at Future Market Insights, which is available in the full report.
Table 1: Global Market Value (US$ Million) Forecast by Region, 2015 to 2032
Table 2: Global Market Value (US$ Million) Forecast by Test Type, 2015 to 2032
Table 3: Global Market Value (US$ Million) Forecast by Application, 2015 to 2032
Table 4: Global Market Value (US$ Million) Forecast by Product Type, 2015 to 2032
Table 5: Global Market Value (US$ Million) Forecast by Technology, 2015 to 2032
Table 6: North America Market Value (US$ Million) Forecast by Country, 2015 to 2032
Table 7: North America Market Value (US$ Million) Forecast by Test Type, 2015 to 2032
Table 8: North America Market Value (US$ Million) Forecast by Application, 2015 to 2032
Table 9: North America Market Value (US$ Million) Forecast by Product Type, 2015 to 2032
Table 10: North America Market Value (US$ Million) Forecast by Technology, 2015 to 2032
Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2015 to 2032
Table 12: Latin America Market Value (US$ Million) Forecast by Test Type, 2015 to 2032
Table 13: Latin America Market Value (US$ Million) Forecast by Application, 2015 to 2032
Table 14: Latin America Market Value (US$ Million) Forecast by Product Type, 2015 to 2032
Table 15: Latin America Market Value (US$ Million) Forecast by Technology, 2015 to 2032
Table 16: Europe Market Value (US$ Million) Forecast by Country, 2015 to 2032
Table 17: Europe Market Value (US$ Million) Forecast by Test Type, 2015 to 2032
Table 18: Europe Market Value (US$ Million) Forecast by Application, 2015 to 2032
Table 19: Europe Market Value (US$ Million) Forecast by Product Type, 2015 to 2032
Table 20: Europe Market Value (US$ Million) Forecast by Technology, 2015 to 2032
Table 21: Asia Pacific Market Value (US$ Million) Forecast by Country, 2015 to 2032
Table 22: Asia Pacific Market Value (US$ Million) Forecast by Test Type, 2015 to 2032
Table 23: Asia Pacific Market Value (US$ Million) Forecast by Application, 2015 to 2032
Table 24: Asia Pacific Market Value (US$ Million) Forecast by Product Type, 2015 to 2032
Table 25: Asia Pacific Market Value (US$ Million) Forecast by Technology, 2015 to 2032
Table 26: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2015 to 2032
Table 27: Middle East and Africa Market Value (US$ Million) Forecast by Test Type, 2015 to 2032
Table 28: Middle East and Africa Market Value (US$ Million) Forecast by Application, 2015 to 2032
Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Product Type, 2015 to 2032
Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Technology, 2015 to 2032
Figure 1: Global Market Value (US$ Million) by Test Type, 2022 to 2032
Figure 2: Global Market Value (US$ Million) by Application, 2022 to 2032
Figure 3: Global Market Value (US$ Million) by Product Type, 2022 to 2032
Figure 4: Global Market Value (US$ Million) by Technology, 2022 to 2032
Figure 5: Global Market Value (US$ Million) by Region, 2022 to 2032
Figure 6: Global Market Value (US$ Million) Analysis by Region, 2015 to 2032
Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032
Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032
Figure 9: Global Market Value (US$ Million) Analysis by Test Type, 2015 to 2032
Figure 10: Global Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032
Figure 11: Global Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032
Figure 12: Global Market Value (US$ Million) Analysis by Application, 2015 to 2032
Figure 13: Global Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 14: Global Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 15: Global Market Value (US$ Million) Analysis by Product Type, 2015 to 2032
Figure 16: Global Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 17: Global Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 18: Global Market Value (US$ Million) Analysis by Technology, 2015 to 2032
Figure 19: Global Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 20: Global Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 21: Global Market Attractiveness by Test Type, 2022 to 2032
Figure 22: Global Market Attractiveness by Application, 2022 to 2032
Figure 23: Global Market Attractiveness by Product Type, 2022 to 2032
Figure 24: Global Market Attractiveness by Technology, 2022 to 2032
Figure 25: Global Market Attractiveness by Region, 2022 to 2032
Figure 26: North America Market Value (US$ Million) by Test Type, 2022 to 2032
Figure 27: North America Market Value (US$ Million) by Application, 2022 to 2032
Figure 28: North America Market Value (US$ Million) by Product Type, 2022 to 2032
Figure 29: North America Market Value (US$ Million) by Technology, 2022 to 2032
Figure 30: North America Market Value (US$ Million) by Country, 2022 to 2032
Figure 31: North America Market Value (US$ Million) Analysis by Country, 2015 to 2032
Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 34: North America Market Value (US$ Million) Analysis by Test Type, 2015 to 2032
Figure 35: North America Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032
Figure 36: North America Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032
Figure 37: North America Market Value (US$ Million) Analysis by Application, 2015 to 2032
Figure 38: North America Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 39: North America Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 40: North America Market Value (US$ Million) Analysis by Product Type, 2015 to 2032
Figure 41: North America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 42: North America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 43: North America Market Value (US$ Million) Analysis by Technology, 2015 to 2032
Figure 44: North America Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 45: North America Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 46: North America Market Attractiveness by Test Type, 2022 to 2032
Figure 47: North America Market Attractiveness by Application, 2022 to 2032
Figure 48: North America Market Attractiveness by Product Type, 2022 to 2032
Figure 49: North America Market Attractiveness by Technology, 2022 to 2032
Figure 50: North America Market Attractiveness by Country, 2022 to 2032
Figure 51: Latin America Market Value (US$ Million) by Test Type, 2022 to 2032
Figure 52: Latin America Market Value (US$ Million) by Application, 2022 to 2032
Figure 53: Latin America Market Value (US$ Million) by Product Type, 2022 to 2032
Figure 54: Latin America Market Value (US$ Million) by Technology, 2022 to 2032
Figure 55: Latin America Market Value (US$ Million) by Country, 2022 to 2032
Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2015 to 2032
Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 59: Latin America Market Value (US$ Million) Analysis by Test Type, 2015 to 2032
Figure 60: Latin America Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032
Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032
Figure 62: Latin America Market Value (US$ Million) Analysis by Application, 2015 to 2032
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 65: Latin America Market Value (US$ Million) Analysis by Product Type, 2015 to 2032
Figure 66: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 68: Latin America Market Value (US$ Million) Analysis by Technology, 2015 to 2032
Figure 69: Latin America Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 70: Latin America Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 71: Latin America Market Attractiveness by Test Type, 2022 to 2032
Figure 72: Latin America Market Attractiveness by Application, 2022 to 2032
Figure 73: Latin America Market Attractiveness by Product Type, 2022 to 2032
Figure 74: Latin America Market Attractiveness by Technology, 2022 to 2032
Figure 75: Latin America Market Attractiveness by Country, 2022 to 2032
Figure 76: Europe Market Value (US$ Million) by Test Type, 2022 to 2032
Figure 77: Europe Market Value (US$ Million) by Application, 2022 to 2032
Figure 78: Europe Market Value (US$ Million) by Product Type, 2022 to 2032
Figure 79: Europe Market Value (US$ Million) by Technology, 2022 to 2032
Figure 80: Europe Market Value (US$ Million) by Country, 2022 to 2032
Figure 81: Europe Market Value (US$ Million) Analysis by Country, 2015 to 2032
Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 84: Europe Market Value (US$ Million) Analysis by Test Type, 2015 to 2032
Figure 85: Europe Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032
Figure 86: Europe Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032
Figure 87: Europe Market Value (US$ Million) Analysis by Application, 2015 to 2032
Figure 88: Europe Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 89: Europe Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 90: Europe Market Value (US$ Million) Analysis by Product Type, 2015 to 2032
Figure 91: Europe Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 92: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 93: Europe Market Value (US$ Million) Analysis by Technology, 2015 to 2032
Figure 94: Europe Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 95: Europe Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 96: Europe Market Attractiveness by Test Type, 2022 to 2032
Figure 97: Europe Market Attractiveness by Application, 2022 to 2032
Figure 98: Europe Market Attractiveness by Product Type, 2022 to 2032
Figure 99: Europe Market Attractiveness by Technology, 2022 to 2032
Figure 100: Europe Market Attractiveness by Country, 2022 to 2032
Figure 101: Asia Pacific Market Value (US$ Million) by Test Type, 2022 to 2032
Figure 102: Asia Pacific Market Value (US$ Million) by Application, 2022 to 2032
Figure 103: Asia Pacific Market Value (US$ Million) by Product Type, 2022 to 2032
Figure 104: Asia Pacific Market Value (US$ Million) by Technology, 2022 to 2032
Figure 105: Asia Pacific Market Value (US$ Million) by Country, 2022 to 2032
Figure 106: Asia Pacific Market Value (US$ Million) Analysis by Country, 2015 to 2032
Figure 107: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 108: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 109: Asia Pacific Market Value (US$ Million) Analysis by Test Type, 2015 to 2032
Figure 110: Asia Pacific Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032
Figure 111: Asia Pacific Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032
Figure 112: Asia Pacific Market Value (US$ Million) Analysis by Application, 2015 to 2032
Figure 113: Asia Pacific Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 114: Asia Pacific Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 115: Asia Pacific Market Value (US$ Million) Analysis by Product Type, 2015 to 2032
Figure 116: Asia Pacific Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 117: Asia Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 118: Asia Pacific Market Value (US$ Million) Analysis by Technology, 2015 to 2032
Figure 119: Asia Pacific Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 120: Asia Pacific Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 121: Asia Pacific Market Attractiveness by Test Type, 2022 to 2032
Figure 122: Asia Pacific Market Attractiveness by Application, 2022 to 2032
Figure 123: Asia Pacific Market Attractiveness by Product Type, 2022 to 2032
Figure 124: Asia Pacific Market Attractiveness by Technology, 2022 to 2032
Figure 125: Asia Pacific Market Attractiveness by Country, 2022 to 2032
Figure 126: Middle East and Africa Market Value (US$ Million) by Test Type, 2022 to 2032
Figure 127: Middle East and Africa Market Value (US$ Million) by Application, 2022 to 2032
Figure 128: Middle East and Africa Market Value (US$ Million) by Product Type, 2022 to 2032
Figure 129: Middle East and Africa Market Value (US$ Million) by Technology, 2022 to 2032
Figure 130: Middle East and Africa Market Value (US$ Million) by Country, 2022 to 2032
Figure 131: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2015 to 2032
Figure 132: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 133: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 134: Middle East and Africa Market Value (US$ Million) Analysis by Test Type, 2015 to 2032
Figure 135: Middle East and Africa Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032
Figure 136: Middle East and Africa Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032
Figure 137: Middle East and Africa Market Value (US$ Million) Analysis by Application, 2015 to 2032
Figure 138: Middle East and Africa Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 139: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 140: Middle East and Africa Market Value (US$ Million) Analysis by Product Type, 2015 to 2032
Figure 141: Middle East and Africa Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 142: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 143: Middle East and Africa Market Value (US$ Million) Analysis by Technology, 2015 to 2032
Figure 144: Middle East and Africa Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 145: Middle East and Africa Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 146: Middle East and Africa Market Attractiveness by Test Type, 2022 to 2032
Figure 147: Middle East and Africa Market Attractiveness by Application, 2022 to 2032
Figure 148: Middle East and Africa Market Attractiveness by Product Type, 2022 to 2032
Figure 149: Middle East and Africa Market Attractiveness by Technology, 2022 to 2032
Figure 150: Middle East and Africa Market Attractiveness by Country, 2022 to 2032
The global HPV Testing and Pap Test market was valued at USD 2.2 Billion in 2021.
The HPV Testing and Pap Test industry is set to witness a growth rate of 19.3% over the forecast period and be valued at USD 15 Billion by 2032.
The HPV Testing and Pap Test market expanded by 17.2% from 2015 through 2021.
Abbott Laboratories, Qiagen N.V., Becton, Dickinson and Company, Quest Diagnostics, Inc., Hologic, Inc., F. Hoffmann-La Roche, Femasys, Inc., Arbor Vita Corporation, NURX, Inc., Seegene, Inc., Thermo Fisher Scientific. Inc., bioMérieux SA are some of the key players in the market.
The USA, United Kingdom, China, Japan, and South Korea are expected to be the key drivers of sales.
The market in the USA accounts for over 39% of the global market.
Explore Similar Insights
HPV Testing and Pap Test Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
